Document Detail


Sexual dimorphism of cardiovascular responses to early blockade of bradykinin receptors.
MedLine Citation:
PMID:  8613235     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To assess whether the cardiovascular effects induced by early blockade of bradykinin B2-receptors with Hoe 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]-bradykinin) are influenced by sex, Wistar rats of both sexes received the antagonist (300 nmol/d per kilogram body wt) or vehicle from 2 days to 7 weeks of age by subcutaneous injection and then by intraperitoneal infusion. Compared with control rats, Hoe 140-treated female rats showed higher systolic blood pressure levels at 7 and 9 weeks of age (125 +/- 2 versus 111 +/- 2 mm Hg and 132 +/- 3 versus 116 +/- 2 mm Hg, respectively, P < .05), whereas in male rats a difference was found at 7 weeks (122 +/- 4 versus 108 +/- 4 mm Hg, P < .05) but not at 9 weeks. At this stage, the mean blood pressure of Hoe 140-treated rats was higher than that of control animals, and this difference was more pronounced at 12 weeks in female rats (121 +/- 2 versus 100 +/- 3 mm Hg in control animals, P < .01) compared with males (116 +/- 3 versus 104 +/- 2 mm Hg in control animals, P < .05). After the first week of life, body weight gain was greater in Hoe 140-treated female rats than in control rats, whereas a group-difference was detected in male rats only after weaning. In Hoe 140-treated female rats, heart weight was already increased at 9 weeks (330 +/- 6 versus 305 +/- 5 mg/100 g body wt in control rats, P < .05), whereas it was necessary to prolong Hoe 140 administration in male rats to develop heart hypertrophy (300 +/- 4 versus 275 +/- 4 mg/100 g body wt in control rats at 12 weeks, P < .05). Tissue kallikrein mRNA levels were higher in the kidney of adult female rats, whereas no sex difference was detected in the heart. The finding of a sexual dimorphism in the cardiovascular response to early blockade of bradykinin receptor suggests that endogenous kinins play a role in the regulation of cardiovascular function in both sexes, but they may be functionally more important in the female rat.
Authors:
P Madeddu; P Pinna Parpaglia; V Anania; N Glorioso; C Chao; C Wang; J Chao
Related Documents :
2757785 - Effects of local application of 5-ht into the median and dorsal raphe nuclei on male ra...
17583705 - Peripherally administered non-peptide oxytocin antagonist, l368,899, accumulates in lim...
10451905 - Dual modulation of male sexual behavior in rats by central prolactin: relationship with...
733835 - Somatic, behavioral, and reproductive disturbances in mice following neonatal administr...
7802715 - Recovery of nocturnal melatonin concentration takes place within one week following ces...
6178985 - Changes in monoamines and their metabolite levels in some brain regions of aged rats.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Hypertension     Volume:  27     ISSN:  0194-911X     ISO Abbreviation:  Hypertension     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1996-06-05     Completed Date:  1996-06-05     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  746-51     Citation Subset:  IM    
Affiliation:
Clinica Medica, University of Sassari, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Pressure / drug effects
Body Weight / drug effects
Bradykinin / administration & dosage,  analogs & derivatives*
Cardiovascular Physiological Phenomena*
Female
Kallikreins / analysis
Male
Rats
Receptors, Bradykinin / antagonists & inhibitors,  physiology*
Sex Characteristics*
Grant Support
ID/Acronym/Agency:
HL-29397/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Receptors, Bradykinin; 130308-48-4/icatibant; 58-82-2/Bradykinin; EC 3.4.21.-/Kallikreins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased responsiveness and decreased expression of G proteins in deoxycorticosterone hypertension.
Next Document:  Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.